Clinical Trials
3
Active:2
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 3
1 (50.0%)Equivalence Study of Dorzolamide 2% Eye Drops Solution
Phase 3
Completed
- Conditions
- Open Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2009-04-09
- Last Posted Date
- 2010-02-12
- Lead Sponsor
- Alfred E. Tiefenbacher (GmbH & Co. KG)
- Target Recruit Count
- 32
- Registration Number
- NCT00878917
- Locations
- 🇩🇪
Department of Opthalmology, Johannes-Gutenberg University Mainz, Mainz, Rheinland-Pfalz, Germany
News
No news found